首页> 外文期刊>Archives of Pharmacal Research >Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique
【24h】

Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique

机译:通过喷雾干燥技术开发具有改善的口服生物利用度的雷洛昔芬固体分散体

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to develop a raloxifene-loaded solid dispersion with enhanced dissolution rate and bioavailability via spray-drying technique. Solid dispersions of raloxifene (RXF) were prepared with PVP K30 at weight ratios of 1:4, 1:6 and 1:8 using a spray-drying method, and characterized by differential scanning calorimetry, X-ray powder diffraction, scanning electron microscopy, and solubility and dissolution tests. The bioavailability of the solid dispersion in rats was also evaluated compared to those of RXF powder and commercial product. Results showed that the RXF-loaded solid dispersion was in amorphous form with increased solubility and dissolution rate. The absorption of RXF from solid dispersion resulted in approximately 2.6-fold enhanced bioavailability compared to pure drug. Moreover, RXF-loaded solid dispersion gave similar AUC, Cmax and Tmax values to the commercial product, suggesting that it was bioequivalent to the commercial product in rats. These findings suggest that an amorphous solid dispersion of RXF could be a viable option for enhancing the oral bioavailability of RXF.
机译:这项研究的目的是通过喷雾干燥技术开发一种具有雷洛昔芬负载的固体分散体,该分散体具有更高的溶解速率和生物利用度。雷诺昔芬(RXF)的固体分散体是通过喷雾干燥法以重量比为1:4、1:6和1:8的PVP K30制备的,并通过差示扫描量热法,X射线粉末衍射,扫描电子显微镜进行表征以及溶解度和溶出度测试。与RXF粉末和市售产品相比,还评估了固体分散体在大鼠中的生物利用度。结果表明,负载RXF的固体分散体为无定形形式,具有增加的溶解度和溶解速率。与纯药物相比,从固体分散体吸收RXF的生物利用度提高了约2.6倍。此外,负载RXF的固体分散体与商业产品具有相似的AUC,Cmax和Tmax值,表明它在大鼠中与商业产品具有生物等效性。这些发现表明,RXF的无定形固体分散体可能是增强RXF口服生物利用度的可行选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号